Keeping abreast of axillary masses

The Lancet

Volumn 380, Issue 9852, 2012, Pages 1530-

  Lee, Michelle ^a   Cooper, Brenda ^a   Becker, Devra ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BRENTUXIMAB VEDOTIN; CD15 ANTIGEN; CISPLATIN; DACARBAZINE; DOXORUBICIN; GEMCITABINE; TRANSCRIPTION FACTOR PAX5; VINBLASTINE;

ADULT; AXILLARY MASS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MULTIPLE CYCLE TREATMENT; NOTE; PRIORITY JOURNAL; SALVAGE THERAPY;

EID: 84867833510     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61334-8     Document Type: Article

References (5)

1. Ferreri AJM, Govi S, Pileri S, et al. Anaplastic Large Cell Lymphoma, ALK-negative. Crit Rev Oncol Hematol (in press).
2. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants JAMA 2008; 300: 2030-35.
3. Aladily T, Medeiros JL, Amin MB, et al. Anaplastic Large Cell Lymphoma Associated with Breast Implants: a report of 13 cases. Am J Surg Pathol 2012; 36: 1000-08.
4. Smith TJ, Ramsaroop R. Breast implant related Anaplastic Large Cell Lymphoma presenting as late onset peri-implant effusion. Breast 2011; 21: 102-04.
5. Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg 2011; 128: 629-39.